BN Business News
Add your company to Business Communicator →

Regulation & law · 05/08/2015Updated: 10/17/2026 · 1 min read

Patheon Pharmaceuticals, Inc. Receives DEA Registration for Controlled Substance Manufacturing

The Drug Enforcement Administration (DEA) has granted Patheon Pharmaceuticals, Inc. registration as a manufacturer of a specific class of controlled substances, following its application.

Original source language: Federal Register — Justice DepartmentOpen original release →

Explore insights

Business insights →